Rare oral lesions from cytomegalovirus in kidney transplant
Postgrad Med J
.
2022 Feb 1;98(e1):e32.
doi: 10.1136/postgradmedj-2021-140516.
Epub 2021 Jun 30.
Authors
Mohankumar Doraiswamy
1
,
Todd E Pesavento
2
,
Deepali Pandey
3
,
Raja Damayanthi Murali
4
,
Priyamvada Singh
1
Affiliations
1
Comprehensive Transplant Center, Division of Nephrology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
2
Comprehensive Transplant Center, Division of Nephrology, The Ohio State University Medical Center, Columbus, Ohio, USA.
3
Division of Hematology and Oncology, University of Kentucky Medical Center, Lexington, Kentucky, USA.
4
MetroHealth Medical Center, Cleveland, Ohio, USA.
PMID:
37066583
PMCID:
PMC8819655
DOI:
10.1136/postgradmedj-2021-140516
No abstract available
Keywords:
clinical pharmacology; infectious diseases; renal transplantation.
MeSH terms
Antiviral Agents / therapeutic use
Cytomegalovirus*
Humans
Kidney Transplantation* / adverse effects
Substances
Antiviral Agents